Kissei Pharmaceutical Co., Ltd.
Clinical trials sponsored by Kissei Pharmaceutical Co., Ltd., explained in plain language.
-
New drug tested to ease debilitating fibroid symptoms
Symptom relief CompletedThis study tested whether an investigational drug called KLH-2109 could better reduce heavy menstrual bleeding and pain in women with uterine fibroids compared to a placebo. It involved 89 premenopausal Japanese women who experienced these symptoms. The main goal was to see if th…
Phase: PHASE3 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Mar 30, 2026 14:32 UTC
-
New drug tested to relieve debilitating itch for dialysis patients
Symptom relief CompletedThis study tested whether an investigational drug called MR13A9 could reduce severe itching in people receiving hemodialysis for kidney disease. In the first part, 178 participants were randomly assigned to receive either MR13A9 or a placebo (a dummy treatment) for 4 weeks to see…
Phase: PHASE3 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Mar 18, 2026 14:41 UTC
-
New drug tested to relieve debilitating itch for dialysis patients
Symptom relief CompletedThis study tested an investigational drug called MR13A9 to see if it could safely reduce severe itching in people receiving hemodialysis for kidney disease. It involved 247 Japanese patients who experienced significant itch despite treatment. Researchers compared different doses …
Phase: PHASE2 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Mar 11, 2026 14:54 UTC